11/29
12:31 am
spro
Spero Therapeutics (NASDAQ:SPRO) was upgraded by analysts at
Wall Street
Medium
Report
Spero Therapeutics (NASDAQ:SPRO) was upgraded by analysts at
Wall Street
11/28
08:05 am
spro
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Neutral
Report
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
11/28
08:00 am
spro
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Neutral
Report
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
11/4
04:05 pm
spro
Spero Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 13, 2025
Medium
Report
Spero Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 13, 2025
10/21
02:00 am
spro
PIVOT-PO Phase 3 Data Show Tebipenem HBr’s Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs)
Medium
Report
PIVOT-PO Phase 3 Data Show Tebipenem HBr’s Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs)
10/15
07:11 am
spro
Spero Therapeutics (NASDAQ:SPRO) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medium
Report
Spero Therapeutics (NASDAQ:SPRO) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
10/14
08:00 am
spro
Spero Therapeutics Announces Presentations on Tebipenem Hbr at IDWeek
Low
Report
Spero Therapeutics Announces Presentations on Tebipenem Hbr at IDWeek
10/10
08:11 pm
spro
Best Momentum Stock to Buy for October 10th [Yahoo! Finance]
Low
Report
Best Momentum Stock to Buy for October 10th [Yahoo! Finance]
10/8
07:29 am
spro
Spero Therapeutics (NASDAQ:SPRO) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Medium
Report
Spero Therapeutics (NASDAQ:SPRO) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.